Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Mesothelioma × Nivolumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Melanoma 3 Carcinoma, Renal Cell 3 Various Advanced Cancer 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Stomach Neoplasms 1 Neoplasms 1 Microsatellite Unstable Colorectal Cancer 1 Mesothelioma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Advanced or Metastatic Solid Tumors 1 Advanced Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 2 Pemetrexed 2 Cisplatin 2 Nivolumab 1 Ipilimumab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02899299 2024-05-21

CheckMate743

Bristol-Myers Squibb

Phase 3 Completed

605 enrolled 17 charts 2 FDA

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡